1887

Abstract

Members of the order express their genes in a transcription gradient from 3′ to 5′. To assess how this impacts on expression of a foreign transgene, the haemagglutinin (HA) of highly pathogenic avian influenza virus (HPAIV) A/chicken/Vietnam/P41/05 (subtype H5N1) was inserted between the phosphoprotein (P) and matrix protein (M), M and fusion protein (F), or F and haemagglutinin–neuraminidase protein (HN) genes of attenuated Newcastle disease virus (NDV) Clone 30. In addition, the gene encoding the neuraminidase of HPAIV A/duck/Vietnam/TG24-01/05 (subtype H5N1) was inserted into the NDV genome either alone or in combination with the HA gene. All recombinants replicated well in embryonated chicken eggs. The expression levels of HA-specific mRNA and protein were quantified by Northern blot analysis and mass spectrometry, with good correlation. HA expression levels differed only moderately and were highest in the recombinant carrying the HA insertion between the F and HN genes of NDV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.027268-0
2011-02-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/2/355.html?itemId=/content/journal/jgv/10.1099/vir.0.027268-0&mimeType=html&fmt=ahah

References

  1. Alexander, D. J.(1997). Newcastle disease and other avian Paramyxoviridae infections. In Diseases of Poultry, 10th edn, pp. 541–569. Edited by Calnek, B. W.. Ames, IA. : Iowa State Press. [Google Scholar]
  2. Buchholz, U. J., Finke, S. & Conzelmann, K. K.(1999). Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73, 251–259. [Google Scholar]
  3. Chen, Z., Matsuo, K., Asanuma, H., Takahashi, H., Iwasaki, T., Suzuki, Y., Aizawa, C., Kurata, T. & Tamura, S.(1999). Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 17, 653–659.[CrossRef] [Google Scholar]
  4. Chen, W., Calvo, P. A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., O'Neill, R., Schickli, J. & other authors(2001). A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7, 1306–1312.[CrossRef] [Google Scholar]
  5. Collins, M. S., Bashiruddin, J. B. & Alexander, D. J.(1993). Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity. Arch Virol 128, 363–370.[CrossRef] [Google Scholar]
  6. DiNapoli, J. M., Nayak, B., Yang, L., Finneyfrock, B. W., Cook, A., Andersen, H., Torres-Velez, F., Murphy, B. R., Samal, S. K. & other authors(2010). Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 84, 1489–1503.[CrossRef] [Google Scholar]
  7. Fauquet, C. M., Mayo, M. A., Maniloff, J., Desselberger, U. & Ball, L. A.(2005).Paramyxoviridae. In Virus Taxonomy. Eighth Report of the International Committee on the Taxonomy of Viruses, pp. 655–671. Edited by Fauquet, C. M., Mayo, M. A., Maniloff, J., Desselberger, U. & Ball, L. A.. San Diego, CA. : Elsevier Academic Press. [Google Scholar]
  8. Fouchier, R. A., Munster, V., Wallensten, A., Bestebroer, T. M., Herfst, S., Smith, D., Rimmelzwaan, G. F., Olsen, B. & Osterhaus, A. D.(2005). Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79, 2814–2822.[CrossRef] [Google Scholar]
  9. Fuchs, W., Römer-Oberdörfer, A., Veits, J. & Mettenleiter, T. C.(2009). Novel avian influenza virus vaccines. Rev Sci Tech 28, 319–332. [Google Scholar]
  10. Ge, J., Deng, G., Wen, Z., Tian, G., Wang, Y., Shi, J., Wang, X., Li, Y., Hu, S. & other authors(2007). Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81, 150–158.[CrossRef] [Google Scholar]
  11. Glickman, R. L., Syddall, R. J., Iorio, R. M., Sheehan, J. P. & Bratt, M. A.(1988). Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J Virol 62, 354–356. [Google Scholar]
  12. Johansson, B. E.(1999). Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 17, 2073–2080.[CrossRef] [Google Scholar]
  13. Krishnamurthy, S., Huang, Z. & Samal, S. K.(2000). Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278, 168–182.[CrossRef] [Google Scholar]
  14. Lamb, R. A. & Kolakofsky, D.(2001).Paramyxoviridae: the viruses and their replication. In Fields Virology, 4th edn, pp. 1305–1340. Edited by Knipe, D. M. & Howley, P.. Philadelphia. : Lippincott Williams & Wilkins. [Google Scholar]
  15. Millar, N. S., Chambers, P. & Emmerson, P. T.(1988). Nucleotide sequence of the fusion and haemagglutinin–neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains. J Gen Virol 69, 613–620.[CrossRef] [Google Scholar]
  16. Nagai, Y., Klenk, H. D. & Rott, R.(1976). Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72, 494–508.[CrossRef] [Google Scholar]
  17. Nakaya, T., Cros, J., Park, M. S., Nakaya, Y., Zheng, H., Sagrera, A., Villar, E., Garcia-Sastre, A. & Palese, P.(2001). Recombinant Newcastle disease virus as a vaccine vector. J Virol 75, 11868–11873.[CrossRef] [Google Scholar]
  18. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A. & Mann, M.(2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1, 376–386.[CrossRef] [Google Scholar]
  19. Palese, P. & Shaw, M. L.(2007).Orthomyxoviridae: virus and their replication. In Fields Virology, 5th edn, pp. 1647–1689. Edited by Knipe, D. M. & Howley, P. M.. Philadelphia. : Lippincott Williams & Wilkins. [Google Scholar]
  20. Park, M. S., Steel, J., García-Sastre, A., Swayne, D. & Palese, P.(2006). Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A 103, 8203–8208.[CrossRef] [Google Scholar]
  21. Pavlova, S. P., Veits, J., Keil, G. M., Mettenleiter, T. C. & Fuchs, W.(2009). Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine 27, 773–785.[CrossRef] [Google Scholar]
  22. Peeters, B. P., de Leeuw, O. S., Koch, G. & Gielkens, A. L.(1999). Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73, 5001–5009. [Google Scholar]
  23. Qiao, C. L., Yu, K. Z., Jiang, Y. P., Jia, Y. Q., Tian, G. B., Liu, M., Deng, G. H., Wang, X. R., Meng, Q. W. & Tang, X. Y.(2003). Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol 32, 25–32.[CrossRef] [Google Scholar]
  24. Römer-Oberdörfer, A., Mundt, E., Mebatsion, T., Buchholz, U. J. & Mettenleiter, T. C.(1999). Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 80, 2987–2995. [Google Scholar]
  25. Römer-Oberdörfer, A., Veits, J., Helferich, D. & Mettenleiter, T. C.(2008). Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine 26, 2307–2313.[CrossRef] [Google Scholar]
  26. Sakai, Y., Kiyotani, K., Fukumura, M., Asakawa, M., Kato, A., Shioda, T., Yoshida, T., Tanaka, A., Hasegawa, M. & other authors(1999). Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Lett 456, 221–226.[CrossRef] [Google Scholar]
  27. Schröer, D., Veits, J., Grund, C., Dauber, M., Keil, G., Granzow, H., Mettenleiter, T. C. & Römer-Oberdörfer, A.(2009). Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus. Avian Dis 53, 190–197.[CrossRef] [Google Scholar]
  28. Skiba, M., Mettenleiter, T. C. & Karger, A.(2008). Quantitative whole-cell proteome analysis of pseudorabies virus-infected cells. J Virol 82, 9689–9699.[CrossRef] [Google Scholar]
  29. Skiba, M., Glowinski, F., Koczan, D., Mettenleiter, T. C. & Karger, A.(2010). Gene expression profiling of Pseudorabies virus (PrV) infected bovine cells by combination of transcript analysis and quantitative proteomic techniques. Vet Microbiol 143, 14–20.[CrossRef] [Google Scholar]
  30. Steward, M., Vipond, I. B., Millar, N. S. & Emmerson, P. T.(1993). RNA editing in Newcastle disease virus. J Gen Virol 74, 2539–2547.[CrossRef] [Google Scholar]
  31. Toyoda, T., Sakaguchi, T., Imai, K., Inocencio, N. M., Gotoh, B., Hamaguchi, M. & Nagai, Y.(1987). Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158, 242–247.[CrossRef] [Google Scholar]
  32. Veits, J., Wiesner, D., Fuchs, W., Hoffmann, B., Granzow, H., Starick, E., Mundt, E., Schirrmeier, H., Mebatsion, T. & other authors(2006). Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A 103, 8197–8202.[CrossRef] [Google Scholar]
  33. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M. & Kawaoka, Y.(1992). Evolution and ecology of influenza A viruses. Microbiol Rev 56, 152–179. [Google Scholar]
  34. Wertz, G. W., Perepelitsa, V. P. & Ball, L. A.(1998). Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. Proc Natl Acad Sci U S A 95, 3501–3506.[CrossRef] [Google Scholar]
  35. Wertz, G. W., Moudy, R. & Ball, L. A.(2002). Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression. J Virol 76, 7642–7650.[CrossRef] [Google Scholar]
  36. Whelan, S. P., Barr, J. N. & Wertz, G. W.(2004). Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol 283, 61–119. [Google Scholar]
  37. Zhao, H. & Peeters, B. P.(2003). Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication. J Gen Virol 84, 781–788.[CrossRef] [Google Scholar]
/content/journal/jgv/10.1099/vir.0.027268-0
Loading
/content/journal/jgv/10.1099/vir.0.027268-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error